'Forgotten' intrauterine device leading to actinomycotic pyometra--13 years after menopause
Kriplani, A.; Buckshee, K.; Relan, S.; Kapila, K.
European Journal of Obstetrics Gynecology and Reproductive Biology 53(3): 215-216
1994
ISSN/ISBN: 0301-2115 PMID: 8200470 DOI: 10.1016/0028-2243(94)90122-8Document Number: 285980
A case of a 'forgotten' intrauterine device (IUD) in a postmenopausal woman leading to Actinomyces israelii infection and pyometra is described. The patient was asymptomatic for 22 years after IUD insertion and developed the complications 13 years after menopause. To prevent such serious complications, it is important to ensure that intrauterine devices, once they have served the purpose and even if they are asymptomatic, are removed.
Document emailed within 0-6 h
Related Documents
Li, C-Hsu.; Chang, W-Chun. 2008: Spontaneous perforated pyometra with an intrauterine device in menopause: a case report Japanese Journal of Infectious Diseases 61(6): 477-478Chuang, C.-J.; Hung, Y.-C.; Hsieh, M.-C.; Hsu, C.-S. 2013: Huge asymptomatic pyometra with an intrauterine device Taiwanese Journal of Obstetrics and Gynecology 52(3): 426-427
Munteanu, O.; Cirstoiu, M.; Antoniac, I.; Cirstoiu, C. 2016: Comparison of Pain Level During and After Intrauterine Device Insertion: Levonorgestrel-Releasing Intrauterine System Versus the Copper T Intrauterine Device Environmental Engineering and Management Journal 15(5): 965-972
Imperato, F.; Perniola, G.; Mossa, B.; Marziani, R.; Perniola, F.; Stragapede, B.; Napolitano, C. 2002: The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years) Minerva Ginecologica 54(3): 271-278
Andolsek, L.; Teeter, R.A.; Kozuh Novak, M.; Wheeler, R.; Fortney, J.A.; Rosenberg, M.J. 1986: Time to conception after intrauterine device removal importance of duration of use intrauterine device type pelvic inflammatory disease and age International Journal of Gynecology and Obstetrics 24(3): 217-224
Brunie, A.él.; Stankevitz, K.; Nwala, A.A.; Nqumayo, M.; Chen, M.; Danna, K.; Afolabi, K.; Rademacher, K.H. 2021: Expanding long-acting contraceptive options: a prospective cohort study of the hormonal intrauterine device, copper intrauterine device, and implants in Nigeria and Zambia LANCET. Global Health 9(10): E1431-E1441
Brunie, A.él.; Stankevitz, K.; Nwala, A.A.; Nqumayo, M.; Chen, M.; Danna, K.; Afolabi, K.; Rademacher, K.H. 2021: Expanding long-acting contraceptive options: a prospective cohort study of the hormonal intrauterine device, copper intrauterine device, and implants in Nigeria and Zambia LANCET. Global Health 9(10): E1431-E1441
Brunie, A.él.; Stankevitz, K.; Nwala, A.A.; Nqumayo, M.; Chen, M.; Danna, K.; Afolabi, K.; Rademacher, K.H. 2021: Expanding long-acting contraceptive options: a prospective cohort study of the hormonal intrauterine device, copper intrauterine device, and implants in Nigeria and Zambia LANCET. Global Health 9(10): E1431-E1441
Ozgu-Erdinc, A.S.; Tasdemir, U.G.; Uygur, D.; Aktulay, A.; Tasdemir, N.; Gulerman, H.C. 2014: Outcome of intrauterine pregnancies with intrauterine device in place and effects of device location on prognosis Contraception 89(5): 426-430
Blumenthal, P.D.; Goldthwaite, L.M. 2015: Intrauterine Device Insertion During Cesarean Delivery: the Rising Tide of the Postdelivery Intrauterine Device Obstetrics and Gynecology 126(1): 1-2
Sezer, S.D.; Odabaşi, A.R.; Küçük, M.; Yüksel, H. 2011: Lost intrauterine contraceptive device inserted 42 years before: a case report Clinical and Experimental Obstetrics and Gynecology 38(1): 90-93
Roy, S.; Azen, C. 1994: A reanalysis of the Cu-7 intrauterine contraceptive device clinical trial and the incidence of pelvic inflammatory disease: A paradigm for assessing intrauterine contraceptive device safety American Journal of Obstetrics and Gynecology 170(6): 1606
Baveja, R.; Varma, H.C.; Kapoor, S. 1976: Intrauterine contraceptive device-nuclei and nucleolar study of the endometrial glands after three years of use Journal of Obstetrics and Gynaecology of India 26(1): 95-98
Wang, K.; Cheng, Y.; Yang, H.; Tang, Y.H.; Jiang, J.; Ji, F.; Li, L.B.; Wu, S.C. 2016: Effectiveness research of medicated γ intrauterine device and medicated genefix intrauterine device inserted immediately after abortion Zhonghua Fu Chan Ke Za Zhi 51(3): 198-203
Maget, V.; Gromez, A.; Roman, H.; Verspyck, E.; Marpeau, L. 2013: Pelvic inflammatory disease and intrauterine contraceptive device. Monocentric continuous study of 70 cases over 5 years Gynecologie Obstetrique and Fertilite 41(7-8): 437-438
Wang, S.L.; Wu, S.C.; Xin, X.M.; Chen, J.H.; Gao, J. 1992: Three years' experience with levonorgestrel-releasing intrauterine device and Norplant-2 implants: a randomized comparative study Advances in Contraception: the Official Journal of the Society for the Advancement of Contraception 8(2): 105-114
Archer, D.F.; Desoto, K.R.; Baker, J.M. 1999: Interleukin-6 and tumor necrosis factor-α concentrations in the intrauterine cavity of postmenopausal women using an intrauterine delivery system releasing progesterone : A possible mechanism of action of the intrauterine device Contraception (Stoneham) 59(3): 175-179
Archer, D.F.; DeSoto, K.R.; Baker, J.M. 1999: Interleukin-6 and tumor necrosis factor-alpha concentrations in the intrauterine cavity of postmenopausal women using an intrauterine delivery system releasing progesterone. a possible mechanism of action of the intrauterine device Contraception 59(3): 175-179
2009: Dispositifs intra-utérins, alias stérilets : Deuxième partie : Connaître les détails pratiques de la pose d'un dispositif intra-utérin - Intrauterine contraceptive device : Part 2 : Know the practical details of the installation of an intrauterine device la Revue Prescrire 29(305): 202-206
2009: Dispositifs intra-utérins, alias stérilets : Deuxième partie : Connaître les détails pratiques de la pose d'un dispositif intra-utérin - Intrauterine contraceptive device : Part 2 : Know the practical details of the installation of an intrauterine device la Revue Prescrire 29(305): 202-206